Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Naviminol
- Development stage
- Unknown
- Lead developer
- Navil Laboratories
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Naviminol is a nutraceutical multivitamin, multimineral, and amino acid supplement developed and manufactured by Navil Laboratories. Formulated as an oral suspension, it is designed to support strength, stamina, and overall vitality. The formulation contains a comprehensive blend of essential amino acids (including L-lysine, L-leucine, DL-methionine, L-valine, and L-isoleucine), minerals (such as magnesium, zinc, manganese, copper, iodine, chromium, and molybdenum), and vitamins (including vitamins A, B-complex, C, D, and E, folic acid, and biotin). Naviminol is primarily used to address nutritional deficiencies, support muscle health and protein synthesis, and combat oxidative stress.
- Brand names
- NaviminolNaviminol Suspension
- Other names
- Naviminol DropsNaviminol Syrup
Beyond the preview
Go deeper on Naviminol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Naviminol.